Literature DB >> 25760384

The antigluconeogenic activity of cucurbitacins from Momordica charantia.

Jian-Chao Chen1, Clara Bik-San Lau2, Judy Yuet-Wa Chan2, Kwok-Pui Fung2, Ping-Chung Leung2, Jie-Qing Liu1, Lin Zhou1, Ming-Jin Xie3, Ming-Hua Qiu1.   

Abstract

Five new cucurbitacins, kuguacins II-VI (1-5), along with five known analogues (6-10), were obtained from the fruit of Momordica charantia. Structures of the new compounds were elucidated as 5β,19-epoxycucurbit-23-en-7-on-3β,25-diol (1), 5β,19-epoxycucurbit-7,23-dion-3β,25-diol (2), 5β,19-epoxycucurbit-6-en-19,23-dion-3β,25-diol (3), 5β,19-epoxy-23,24,25,26,27-pentanorcucurbit-6-en-7,19-dion-3β,22-diol (4), and cucurbit-5-en-7,23-dion-3β,19,25-triol (5) by extensive spectroscopic and single-crystal X-ray diffraction analyses. Some cucurbitane compounds from this species were screened for their potential antidiabetic properties in terms of antigluconeogenic activity. As a result, compounds 1, 10, 11, and 12 (at 25-100 µM) showed concentration-dependent inhibition on glucose production from liver cells. In addition, compounds 11 and 12 (at 100 µM) showed around 20-30 % inhibition on PEPCK activity. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25760384     DOI: 10.1055/s-0035-1545695

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  5 in total

Review 1.  Momordica charantia L.-Diabetes-Related Bioactivities, Quality Control, and Safety Considerations.

Authors:  Serhat S Çiçek
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

Review 2.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

Review 3.  Three Selected Edible Crops of the Genus Momordica as Potential Sources of Phytochemicals: Biochemical, Nutritional, and Medicinal Values.

Authors:  Mashudu Muronga; Cristina Quispe; Phumudzo P Tshikhudo; Titus A M Msagati; Fhatuwani N Mudau; Miquel Martorell; Bahare Salehi; Ahmad Faizal Abdull Razis; Usman Sunusi; Ramla Muhammad Kamal; Javad Sharifi-Rad
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 4.  Phytomedicines Used for Diabetes Mellitus in Ghana: A Systematic Search and Review of Preclinical and Clinical Evidence.

Authors:  Michael Buenor Adinortey; Rosemary Agbeko; Daniel Boison; William Ekloh; Lydia Enyonam Kuatsienu; Emmanuel Ekow Biney; Obed O Affum; Jeffery Kwarteng; Alexander Kwadwo Nyarko
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-18       Impact factor: 2.629

5.  Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of Momordica charantia L.

Authors:  Wilmer H Perera; Siddanagouda R Shivanagoudra; Jose L Pérez; Da Mi Kim; Yuxiang Sun; Guddadarangavvanahally K Jayaprakasha; Bhimanagouda S Patil
Journal:  Molecules       Date:  2021-02-16       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.